A small amount of blood at the injection site is normal and happens occasionally when the needle nicks a small capillary
For an individual with a BMI over 30 who is already managing heart disease, the weight loss achieved through a personalized program can significantly reduce the strain on the cardiovascular system
Retatrutide is administered as a once-weekly subcutaneous injection, similar in delivery to other peptide-based obesity treatments currently available
Try Inside Rx for up to 80% savings Inside Rx may be able to help you save up to 80% on your prescription medications including GLP-1s at 60,000 pharmacies nationwide
Published Phase 2 trial data (for example, Jastreboff et al., NEJM 2023) have explored doses ranging from approximately 1 mg up to 12 mg administered once weekly
Key published studies include: Jastreboff AM, et al